Delivery Order SPE2DR25D1100-SPE2DR26FCS3W
Award Date 12/2/25
Potential Completion Date 12/3/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used in medical settings. This firm fixed-price delivery order, valued at $5,429.76, is scheduled for completion by August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp was awarded a $3,174.48 delivery order by the Defense Logistics Agency on August 25, 2025, for the supply of Cathflo Activase 2 mg vials, with ultimate completion scheduled for August 26, 2025. This firm fixed-price contract, which was not set-aside, represents a small-value pharmaceutical procurement fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award is issued as a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,429.76 by the Defense Logistics Agency for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used in medical applications. The award was made on September 17, 2025, under a firm fixed-price contract type with an ultimate completion date of September 18, 2025. This non-set-aside delivery order will be performed at the awardee's location in Conshohocken, Pennsylvania. As a child contract, this delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a $3,393.60 delivery order by the Defense Logistics Agency (DLA) for Cathflo Activase 2 mg vials. The award, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, represents a firm fixed-price competitively awarded contract with no set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 8, 2025, for the supply of Cathflo Activase 2 mg vials with a ceiling value of $2,262.40. This firm fixed-price delivery order is scheduled for completion by September 9, 2025, and represents a competitively awarded, non-set-aside contract. The award is funded through the Medical Supply Chain, a defense-oriented federal agency responsible for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials with a ceiling value of $5,256.48. This firm fixed-price delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a competitively awarded procurement with no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,714.88 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, a thrombolytic medication used in medical settings. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 11, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,838.12 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of June 3, 2025. This non-set-aside, firm fixed price delivery order represents a competitive award to the pharmaceutical distributor for medical supply provision supporting federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical and healthcare solutions...
- The Defense Logistics Agency awarded a $10,533.01 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cathflo Activase 2 mg vials, with an ultimate completion date of October 28, 2025. This non-set-aside contract represents a delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials under a firm fixed price arrangement. The contract, valued at $1,420.63, carries an ultimate completion date of December 2, 2025, and was competitively awarded without set-aside restrictions. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...